Identification and evaluation of novel peptide ligands specific to human CD3 epsilon

Abstract

The present disclosure is directed to anti-CD3ε peptides, compounds, and methods of using same. A biopanning technique was used to identify several phage clones displaying unique anti-CD3ε peptide sequences. The anti-CD3ε peptide sequences bind to human CD3ε on T cells, allowing the identification, labeling, and delivery of cargo to these T cells. Applications for the disclosed peptides include the labeling of T cells with magnetic particles for MRI detection and targeting of T cells with cargo-laden anti-CD3ε peptides for immunotherapy. Further still, incubation of T cells with anti-CD3ε peptides may result in the activation and increase production of T cells, which may in turn be harvested for applications such as CAR-T therapy.

Dependencies are inferred from the claim text.